Platelet-Rich Protein and the Endometrium

Can Platelet-rich Plasma (PRP) Promote Endometrial Growth and Improve Pregnancy Outcome of Patients With Thin Endometrium Undergoing Assisted Reproductive Technology (ART) Treatments?

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02973555

Enrollment

Registered

2016-11-25

Start date

2017-01-31

Completion date

2019-01-31

Last updated

2016-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

Platelet-rich plasma (PRP) may promote the endometrial growth and improve pregnancy outcome of patients with thin endometrium undergoing ART treatments.

Interventions

OTHERPRP injection

autologous intrauterine infusion of PRP

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 54 Years

Healthy volunteers

Inclusion criteria

* Women undergoing a frozen thawed embryo transfer cycle with poor endometrial response to estrogen (\< 7 mm) after at least two standard preparation protocols, of which one was canceled due to thin endometrium

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame
endometrial thickness >7mm	1 month

Secondary

Measure	Time frame
Positive serum pregnancy test	14 days post embryo transfer

Countries

Israel

Contacts

Primary ContactRonit Kochman, MD

kochman@hadassah.org.il+972 508946414

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026